| Structure |
Chemical Name |
CAS |
MF |
 |
(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzamide |
|
C18H22FN5O3 |
 |
Apremilast Impurity 2 |
|
|
 |
Etoricoxib Impurity 16 |
|
|
 |
Ibrutinib Impurity 2 |
2417548-78-6 |
|
 |
Mirabegron Impurity 14 |
|
|
 |
Vonoprazan Impurity 1 |
881732-90-7 |
C17H17N3O2S |
 |
Atenolol EP Impurity |
|
C14H22N2O3 |
 |
Cinacalcet Impurity 20 |
|
|
 |
Dapagliflozin Impurity 11 |
|
|
 |
Dasatinib Impurity C |
|
|
 |
Etoricoxib impurity Q |
292067-97-1 |
C18H15ClN2S |
 |
Flucloxacillin Impurity |
|
|
 |
Fluorometholone Impurity |
2796-99-8 |
C23H31FO7S |
 |
Verapamil Impurity |
1551304-28-9 |
C12H19NO2 |
 |
Clopidogrel impurity reference substance |
|
C15H14ClNO2S |
 |
Vildagliptin Impurity |
|
|
 |
Aloeemodin-ω-O-β-D-glucopyranoside |
29010-56-8 |
C21H20O10 |
![ethyl 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate](/CAS/20200119/GIF/2029205-62-5.gif) |
ethyl 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate |
2029205-62-5 |
C26H25ClN4O4 |
![1-Butanaminium, N,N,N-tributyl-, (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate](/CAS/20180702/GIF/1192651-80-1.gif) |
1-Butanaminium, N,N,N-tributyl-, (1R,2S,5R)-2-(aminocarbonyl)-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl sulfate |
1192651-80-1 |
C23H46N4O6S |
 |
Dihydroxyoxaliplatin(Oxaliplatin Impurity Ⅲ) |
|
|
 |
cefditoren E-isomer(C=C) |
|
|
 |
Mixture of Lamivudine Impurity Ⅳ and Impurity Ⅴ |
|
|
 |
2-Ethoxybenzimidohydrazide |
889943-46-8 |
C9H13N3O |
 |
(E)-2-(6-(methoxycarbonyl)-2-oxoindolin-3-ylidene)-2-phenylacetic acid |
|
C18H13NO5 |
 |
8-Epi-cyanocobalamin |
41325-63-7 |
C63H88CoN14O14P |
 |
Lamivudine Impurity 2 |
200396-21-0 |
C18H27N3O4S |
 |
Lamivudine Impurity 1 |
1235712-40-9 |
C8H11N3O4S |
 |
Moxifloxacin Related Impurity 3 |
|
|
 |
Bisoprolol EP Impurity Q |
1346604-00-9 |
C16H27NO4 |
 |
Levofloxacin N-Oxide |
117678-37-2 |
C18H20FN3O5 |
 |
Oseltamivir EP Impurity A |
1391047-93-0 |
C14H24N2O4 |
 |
Quetiapine EP Impurity N |
1800291-86-4 |
C29H41N5O3S |
 |
Ceftazidime Impurity |
|
|
 |
Chlorhexidine Digluconate Impurity N |
152504-10-4 |
C15H25ClN8 |
 |
S-Azetidin-3-yl ethanethioate HCl |
886615-18-5 |
C5H9NOS |
 |
Olaparib Impurity C |
|
|
 |
Olaparib Impurity F |
|
|
 |
Dapoxetine Impurity 4 |
|
|
 |
Glycopyrrolate impurity 3 |
|
|
 |
Lamotrigine impurity B |
|
|
 |
Ramosetron Impurity 3 |
|
|
 |
Loratadine Impurity 1 |
|
C22H23ClN2O2 |
 |
Metoprolol IMpurity 6 |
|
C15H25NO3 |
 |
Pitavastatin Impurity 5 |
|
|
 |
Prasugrel Impurity C |
|
|
 |
Trifluridine Impurity 2 |
|
|
 |
Cefazolin Impurity 4 |
|
|
 |
Vonoprazan Impurity 3 |
|
|
 |
Cinacalcene Impurity I |
|
|
 |
Valsartan Impurity 2 |
|
C24H29N5O3 |
 |
Istradefylline Impurity 2 |
|
|
 |
Etoricoxib Impurity 3 |
|
|
 |
Apremilast Impurity 5 |
200710-04-9 |
C11H13NO4 |
 |
Topiroxostat Imp.C |
|
|
 |
(3R,4S)-1-(4-chlorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1700622-08-7 |
C24H21ClFNO3 |
 |
Rabeprazole Impurity 2 |
1163685-31-1 |
C11H15NO4 |
 |
Regorafenib Impurity 8 |
|
|
 |
Flomoxef Impurity 5 |
134237-56-2 |
C25H23ClF2N2O6S |
 |
Ranitidine impurity |
94167-82-5 |
C10H18N2O |
 |
nicergoline impurity E |
|
|
![ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate](/CAS/20200119/GIF/CB33130105.gif) |
ethyl(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-(4-ethoxy-4-oxobutanamido)-2-methylpentanoate |
|
C26H33NO5 |
 |
Tacrolimus Impurity C |
|
|
 |
Levodopa impurity 5 |
|
|
![(R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide](/CAS/20180629/GIF/1223404-68-9.gif) |
(R)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
1223404-68-9 |
C21H22F2N6O2 |
 |
Afatinib Impurity 18 |
2316847-95-5 |
C22H20ClFN4O4 |
 |
Ivabradine Impurity 1 Hydrochloride |
85175-52-6 |
C16H25ClN2O3 |
 |
SofosBuvir Impurity 3 |
|
|
 |
phenyl (4-((6-carbamoyl-7-methoxyquinolin-4-yl)oxy)-2-chlorophenyl)carbamate |
417722-95-3 |
C24H18ClN3O5 |
 |
Canagliflozin Impurity 10 |
1672658-93-3 |
C24H25FO6S |
 |
Canagliflozin Impurity F |
|
|
 |
Empagliflozin impurity E |
|
|
 |
Fasudil Impurity 6 |
2044706-58-1 |
C11H11NO3S |
 |
Ibrutinib Impurity 11 |
|
C27H31N7O2 |
 |
Nintedanib impurity I |
334951-61-0 |
C30H31N5O4 |
 |
(Z)-3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylic acid compound with 3-benzoyl-2-oxoindoline-6-carboxylic acid |
1253768-91-0 |
C16H11NO4 |
 |
Everolimus Related Compound 3 |
147438-30-0 |
C32H49NO9 |
 |
(R)-isopropyl 2-(((R)-(perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate |
1627824-09-2 |
C18H17F5NO5P |
 |
Cefuroxime Sodium EP Impurity C |
69822-88-4 |
C15H15N3O6S |
![Acemetacin EP Impurity F/Carboxymethyl Acemetacin/[[[[[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl]oxy]acetyl]oxy]acetic acid](/CAS/20210111/GIF/76812-49-2.gif) |
Acemetacin EP Impurity F/Carboxymethyl Acemetacin/[[[[[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl]oxy]acetyl]oxy]acetic acid |
76812-49-2 |
C23H20ClNO8 |
 |
Cefuroxime Sodium EP Impurity G |
97232-98-9 |
C17H17N3O8S |
 |
2-chloro-4-(cyclopentylamino)-5-pyrimidinyl ethanone |
1244949-62-9 |
C11H14ClN3O |
 |
Cetirizine 3-Chloro Impurity |
1232460-31-9 |
C21H25ClN2O3 |
 |
Donepezil Impurity 8 |
1808997-65-0 |
C18H23NO4 |
 |
Rivaroxaban Impurity 23 |
|
|
 |
(Z)-2-(2-aminothiazol-4-yl)-2-(hydroxyimino)acetamide |
1450758-21-0 |
C5H6N4O2S |
 |
Fosfomycin Trometamol impurity C |
23001-39-0 |
C4H12NO6P |
 |
(R)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile oxalate |
|
C22H23FN2O5 |
 |
1-(7,8-dihydronaphthalen-1-yl)ethan-1-amine hydrochloride |
1822601-94-4 |
C12H15N |
 |
Sofosbuvir metabolites |
1859162-80-3 |
C16H18FN2O8P |
 |
1,3,5,7-tetrahydroxyadamantane |
16104-28-2 |
C10H16O4 |
 |
Cabozantinib Impurity E |
|
|
 |
Loxoprofen Impurity I |
|
|
 |
Sofosbuvir Impurity22 |
|
|
 |
Donepezil Impurity-OH |
148517-82-2 |
C11H12O4 |
![1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one](/CAS/20180528/GIF/13491-41-3.gif) |
1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-(hydroxyamino)pyrimidin-2-one |
13491-41-3 |
C9H13N3O6 |
![5-(hydroxymethyl)-3-[(5-nitro-2-furyl)methylideneamino]oxazolidin-2-one](/CAS/20180529/GIF/41359-15-3.gif) |
5-(hydroxymethyl)-3-[(5-nitro-2-furyl)methylideneamino]oxazolidin-2-one |
41359-15-3 |
C9H9N3O6 |
 |
Axitinib Impurity 14 |
|
|
 |
Nicorandil Impurity 7 |
|
|
 |
Ritonavir EP Impurity T |
869368-48-9 |
C46H66N8O5S2 |
 |
4-Methoxy-a-methyl-L-phenylalanine |
65555-88-6 |
C11H15NO3 |